Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.
Desta Z, Gammal RS, Gong L, Whirl-Carrillo M, Gaur AH, Sukasem C, Hockings J, Myers A, Swart M, Tyndale RF, Masimirembwa C, Iwuchukwu OF, Chirwa S, Lennox J, Gaedigk A, Klein TE, Haas DW. Desta Z, et al. Clin Pharmacol Ther. 2019 Oct;106(4):726-733. doi: 10.1002/cpt.1477. Epub 2019 Jul 5. Clin Pharmacol Ther. 2019. PMID: 31006110 Free PMC article.
Obituary: David Alastair Flockhart , MD, PhD.
Bies R, McDonald C, Desta Z. Bies R, et al. Among authors: desta z. Br J Clin Pharmacol. 2016 Feb;81(2):393-4. doi: 10.1111/bcp.12868. Br J Clin Pharmacol. 2016. PMID: 26852746 Free PMC article. No abstract available.
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.
Abdelhady AM, Shugg T, Thong N, Lu JB, Kreutz Y, Jaynes HA, Robarge JD, Tisdale JE, Desta Z, Overholser BR. Abdelhady AM, et al. Among authors: desta z. J Cardiovasc Electrophysiol. 2016 Oct;27(10):1206-1213. doi: 10.1111/jce.13032. Epub 2016 Jul 25. J Cardiovasc Electrophysiol. 2016. PMID: 27333947 Free PMC article. Clinical Trial.
175 results